[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BaffledBiologist [@BlaseBio](/creator/twitter/BlaseBio) on x XXX followers Created: 2025-07-22 13:59:06 UTC @IC50_cent I'm not sure that's a fair comparison, though. Most pts were treated with pd-1 mono and there's a far less stringent definition of progression (pts who progress anytime versus progress while on PD-1). High skew towards superficial/injectable is fair, but is that CRL worthy? XXX engagements  [Post Link](https://x.com/BlaseBio/status/1947657659848478899)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BaffledBiologist @BlaseBio on x XXX followers
Created: 2025-07-22 13:59:06 UTC
@IC50_cent I'm not sure that's a fair comparison, though. Most pts were treated with pd-1 mono and there's a far less stringent definition of progression (pts who progress anytime versus progress while on PD-1). High skew towards superficial/injectable is fair, but is that CRL worthy?
XXX engagements
